Ashland completes second expansion in Mullingar
Ashland has completed the second expansion of its pharmaceutical injectables manufacturing and R&D lab at the National Science Park in Mullingar, and will celebrate with a ribbon-cutting ceremony on August 22.
This enhancement, completed as scheduled, expands Ashland’s footprint, capabilities and headcount of its Irish facility focused on delivery of innovative bioresorbable polymer chemistry to meet increasing market demand.
Continuing investment also underscores Ashland’s commitment to the company’s new innovative technology platforms announced last September.
One of seven platforms, bioresorbable polymers enable customers to create improved pharmaceuticals, medical devices and tissue engineering solutions.
This project is supported by IDA Ireland.
Minister Peter Burke said: “It is excellent news that Ashland have completed their expansion project on their manufacturing and R&D lab at the National Science Park in Mullingar. This significant investment in my hometown, and in the midlands region, demonstrates Ashland’s commitment to Ireland and further strengthens Ireland as a global leader in the life sciences sector.
“It is encouraging to know that the work undertaken there will lead to innovative medical solutions.
“As Ashland expands, they will find ample talented graduates in the local surrounds and from the nearby Technological University of the Shannon (TUS) to fulfil that growth. All the best to the Ashland team on this momentous occasion.”
Alessandra Faccin, senior vice president and general manager, life sciences, Ashland said Ashland “are actively engaging with our customers to help them solve for performance attributes that reduce injection frequency and yield better therapy outcomes”.
About Ashland
Ashland Inc. (NYSE: ASH) is a global additives and specialty ingredients company with a conscious and proactive mindset for environment, social, and governance (ESG).
The company serves customers in a wide range of consumer and industrial markets, including architectural coatings, construction, energy, food and beverage, nutraceuticals, personal care, and pharmaceutical. Approximately 3,800 passionate, tenacious solvers – from renowned scientists and research chemists to talented engineers and plant operators – thrive on developing practical, innovative, and elegant solutions to complex problems for customers in more than 100 countries.
Visit ashland.com and ashland.com/ESG to learn more.